The KEEPER™ trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology
Reference18 articles.
1. Ben-Menachem, E., Falter, U., for the European Levetiracetam Study Group, 2000. Efficacy and tolerability of levetiracetam 3000 mg per day in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia 41, 1276–1283.
2. A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy;Betts;Seizure,2000
3. Dose–response effect of levetiracetam 1000 and 2000 mg per day in partial epilepsy;Boon;Epilepsy Res.,2002
4. Absence of pharmacokinetic drug interaction of levetiracetam with phenytoin in patients with epilepsy determined by new technique;Browne;J. Clin. Pharmacol.,2000
5. Cereghino, J.J., Biton, V., Abou-Khalil, B., Dreifuss, F., Gauer, L.J., Leppik, I., for the United States Levetiracetam Study Group, 2000. Levetiracetam for partial seizures. Results of a double-blind, randomized clinical trial. Neurology 55, 236–242.
Cited by 95 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil;Neuroscience Bulletin;2023-10-28
2. Comparative efficacy of intravenous levetiracetam and phenytoin in status epilepticus: a systematic review and meta-analysis of randomized controlled trials;Medical Journal of Indonesia;2023-07-18
3. Levetiracetam-Induced Rhabdomyolysis Following Medication Re-Initiation;Cureus;2022-10-07
4. Hematological and Renal Effects of Levetiracetam Versus Lamotrigine in Children With Epilepsy: A Randomized Clinical Trial;Disease and Diagnosis;2022-07-01
5. The Effects of Short- and Long-Term Therapy on Laboratory Parameters Among Pediatric Patients with Epilepsy Receiving Antiepileptic Drug Monotherapy;Archives of Epilepsy;2022-06-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3